1 |
Mukdad L, Heineman TE, Alonso J, et al. Oral tongue squamous cell carcinoma survival as stratified by age and sex: a surveillance, epidemiology, and end results analysis[J]. Laryngoscope, 2019, 129(9): 2076-2081.
|
2 |
Ye H, Yu T, Temam S, et al. Transcriptomic dissection of tongue squamous cell carcinoma[J]. BMC Genomics, 2008, 9: 69.
|
3 |
Hussein AA, Forouzanfar T, Bloemena E, et al. A review of the most promising biomarkers for early diagnosis and pro-gnosis prediction of tongue squamous cell carcinoma[J]. Br J Cancer, 2018, 119(6): 724-736.
|
4 |
Nguyen LK, Kholodenko BN, von Kriegsheim A. Rac1 and RhoA: networks, loops and bistability[J]. Small GTPases, 2018, 9(4): 316-321.
|
5 |
Kim JG, Islam R, Cho JY, et al. Regulation of RhoA GTPase and various transcription factors in the RhoA pathway[J]. J Cell Physiol, 2018, 233(9): 6381-6392.
|
6 |
Cox AD, Der CJ, Philips MR. Targeting RAS membrane association: back to the future for anti-RAS drug disco-very[J]. Clin Cancer Res, 2015, 21(8): 1819-1827.
|
7 |
Roberts PJ, Mitin N, Keller PJ, et al. Rho family GTPase modification and dependence on CAAX motif-signaled posttranslational modification[J]. J Biol Chem, 2008, 283(37): 25150-25163.
|
8 |
Orgaz JL, Herraiz C, Sanz-Moreno V. Rho GTPases mo-dulate malignant transformation of tumor cells[J]. Small GTPases, 2014, 5(4): e29019.
|
9 |
Narumiya S, Tanji M, Ishizaki T. Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion[J]. Cancer Metastasis Rev, 2009, 28(1/2): 65-76.
|
10 |
Wang M, Casey PJ. Protein prenylation: unique fats make their mark on biology[J]. Nat Rev Mol Cell Biol, 2016, 17(2): 110-122.
|
11 |
Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer[J]. Oral Oncol, 2009, 45(4/5): 309-316.
|
12 |
Yang J, Kulkarni K, Manolaridis I, et al. Mechanism of isoprenylcysteine carboxyl methylation from the crystal structure of the integral membrane methyltransferase ICMT[J]. Mol Cell, 2011, 44(6): 997-1004.
|
13 |
Rath N, Olson MF. Rho-associated kinases in tumorige-nesis: re-considering ROCK inhibition for cancer therapy[J]. EMBO Rep, 2012, 13(10): 900-908.
|
14 |
Cushman I, Casey PJ. RHO methylation matters: a role for isoprenylcysteine carboxylmethyltransferase in cell migration and adhesion[J]. Cell Adh Migr, 2011, 5(1): 11-15.
|
15 |
Heriady Y, Achmad D, Hernowo BS, et al. Expression of the RAC1, RHOA and CXCR4 proteins and their interaction as risk factors for infiltration to the nipple areola complex in operable breast carcinoma[J]. Breast Cancer, 2019, 26(2): 172-179.
|
16 |
Nam S, Kim JH, Lee DH. RHOA in gastric cancer: functional roles and therapeutic potential[J]. Front Genet, 2019, 10: 438.
|
17 |
Abraham MT, Kuriakose MA, Sacks PG, et al. Motility-related proteins as markers for head and neck squamous cell cancer[J]. Laryngoscope, 2001, 111(7): 1285-1289.
|
18 |
Kamai T, Tsujii T, Arai K, et al. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer[J]. Clin Cancer Res, 2003, 9(7): 2632-2641.
|
19 |
Dopeso H, Rodrigues P, Bilic J, et al. Mechanisms of inactivation of the tumour suppressor gene RHOA in color-ectal cancer[J]. Br J Cancer, 2018, 118(1): 106-116.
|
20 |
Tanaka K, Matsumoto Y, Ishikawa H, et al. Impact of RhoA overexpression on clinical outcomes in cervical squamous cell carcinoma treated with concurrent chemoradiotherapy[J]. J Radiat Res, 2020, 61(2): 221-230.
|
21 |
Zhu Y, Hu Q, Li H. Isoprenylcysteine carboxylmethyltransferase is associated with nasopharyngeal carcinoma chemoresistance and Ras activation[J]. Biochem Biophys Res Commun, 2019, 516(3): 784-789.
|
22 |
Cushman I, Casey PJ. Role of isoprenylcysteine carboxylmethyltransferase-catalyzed methylation in Rho function and migration[J]. J Biol Chem, 2009, 284(41): 27964-27973.
|
23 |
Borini Etichetti C, Di Benedetto C, Rossi C, et al. Isoprenylcysteine carboxy methyltransferase (ICMT) is associa-ted with tumor aggressiveness and its expression is controlled by the p53 tumor suppressor[J]. J Biol Chem, 2019, 294(13): 5060-5073.
|
24 |
Court H, Amoyel M, Hackman M, et al. Isoprenylcysteine carboxylmethyltransferase deficiency exacerbates KRAS-driven pancreatic neoplasia via Notch suppression[J]. J Clin Invest, 2013, 123(11): 4681-4694.
|
25 |
Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour[J]. Nat Rev Mol Cell Biol, 2003, 4(6): 446-456.
|
26 |
Hetmanski JHR, de Belly H, Busnelli I, et al. Membrane tension orchestrates rear retraction in matrix-directed cell migration[J]. Dev Cell, 2019, 51(4): 460-475.e10.
|
27 |
Bryan BA, Dennstedt E, Mitchell DC, et al. RhoA/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis[J]. FASEB J, 2010, 24(9): 3186-3195.
|
28 |
Roy R, Yang J, Moses MA. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer[J]. J Clin Oncol, 2009, 27(31): 5287-5297.
|
29 |
Aparna M, Rao L, Kunhikatta V, et al. The role of MMP-2 and MMP-9 as prognostic markers in the early stages of tongue squamous cell carcinoma[J]. J Oral Pathol Med, 2015, 44(5): 345-352.
|